Company intelligence / Profile preview

Kern Pharma

Terrassa, Catalonia, Spainkernpharma.com ↗

Ownership: Private
Employees: ~865
Development stage: Commercial

Overview

Kern Pharma develops, manufactures, and commercializes a wide portfolio of generic medicines as well as some branded ethical/hospital products. The company also provides contract manufacturing services for third parties. Its products are widely available in Spain and exported internationally through licensing agreements. No clinical trial results are published since the focus is on generics.

Therapeutic areas: Other
Modalities: Generic small moleculesbranded pharmaceuticalsover-the-counter (OTC) drugs
Industry: Biotech

Drug pipeline

1 asset

KPI-001

Preclinical

Partnerships

Licensing agreements with Spanish and international pharmaceutical firms for distribution/exporting of products

Beyond the preview

Go deeper on Kern Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kern Pharma.

Explore the full profile